IL162594A0 - Process and intermediates for pyridazinone antidiabetic agents - Google Patents
Process and intermediates for pyridazinone antidiabetic agentsInfo
- Publication number
- IL162594A0 IL162594A0 IL16259403A IL16259403A IL162594A0 IL 162594 A0 IL162594 A0 IL 162594A0 IL 16259403 A IL16259403 A IL 16259403A IL 16259403 A IL16259403 A IL 16259403A IL 162594 A0 IL162594 A0 IL 162594A0
- Authority
- IL
- Israel
- Prior art keywords
- pyridazinone
- intermediates
- antidiabetic agents
- antidiabetic
- agents
- Prior art date
Links
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical compound OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 229940125708 antidiabetic agent Drugs 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34767902P | 2002-01-09 | 2002-01-09 | |
| PCT/IB2003/000013 WO2003057691A1 (en) | 2002-01-09 | 2003-01-03 | Process and intermediates for pyridazinone antidiabetic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162594A0 true IL162594A0 (en) | 2005-11-20 |
Family
ID=23364775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16259403A IL162594A0 (en) | 2002-01-09 | 2003-01-03 | Process and intermediates for pyridazinone antidiabetic agents |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6759534B2 (de) |
| EP (1) | EP1463725B1 (de) |
| JP (1) | JP2005514421A (de) |
| KR (1) | KR100604502B1 (de) |
| CN (1) | CN1269814C (de) |
| AR (1) | AR038267A1 (de) |
| AT (1) | ATE302201T1 (de) |
| AU (1) | AU2003200847A1 (de) |
| BR (1) | BR0306730A (de) |
| CA (1) | CA2472331A1 (de) |
| DE (1) | DE60301324T2 (de) |
| DK (1) | DK1463725T3 (de) |
| ES (1) | ES2246464T3 (de) |
| HK (1) | HK1072598A1 (de) |
| HU (1) | HUP0500031A2 (de) |
| IL (1) | IL162594A0 (de) |
| MX (1) | MXPA04005646A (de) |
| PL (1) | PL371258A1 (de) |
| PT (1) | PT1463725E (de) |
| RU (1) | RU2278116C2 (de) |
| TW (1) | TWI250980B (de) |
| WO (1) | WO2003057691A1 (de) |
| ZA (1) | ZA200404798B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL156462A0 (en) * | 2001-03-30 | 2004-01-04 | Pfizer Prod Inc | Pyridazinone aldose reductase inhibitors |
| CN103333144B (zh) * | 2013-06-17 | 2014-12-10 | 温州大学 | 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途 |
| CN105732552B (zh) * | 2016-04-12 | 2017-12-01 | 天津师范大学 | 2位或3‑位硫代苯并呋喃化合物的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3328770A1 (de) * | 1983-08-10 | 1985-02-28 | Basf Ag, 6700 Ludwigshafen | Pyridazinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| IL156462A0 (en) * | 2001-03-30 | 2004-01-04 | Pfizer Prod Inc | Pyridazinone aldose reductase inhibitors |
-
2003
- 2003-01-03 TW TW092100108A patent/TWI250980B/zh not_active IP Right Cessation
- 2003-01-03 IL IL16259403A patent/IL162594A0/xx unknown
- 2003-01-03 PL PL03371258A patent/PL371258A1/xx not_active Application Discontinuation
- 2003-01-03 WO PCT/IB2003/000013 patent/WO2003057691A1/en active IP Right Grant
- 2003-01-03 CN CNB038020114A patent/CN1269814C/zh not_active Expired - Fee Related
- 2003-01-03 KR KR1020047010669A patent/KR100604502B1/ko not_active IP Right Cessation
- 2003-01-03 EP EP03700018A patent/EP1463725B1/de not_active Expired - Lifetime
- 2003-01-03 DK DK03700018T patent/DK1463725T3/da active
- 2003-01-03 MX MXPA04005646A patent/MXPA04005646A/es active IP Right Grant
- 2003-01-03 DE DE60301324T patent/DE60301324T2/de not_active Expired - Fee Related
- 2003-01-03 AU AU2003200847A patent/AU2003200847A1/en not_active Abandoned
- 2003-01-03 HU HU0500031A patent/HUP0500031A2/hu unknown
- 2003-01-03 RU RU2004121026/04A patent/RU2278116C2/ru not_active IP Right Cessation
- 2003-01-03 ES ES03700018T patent/ES2246464T3/es not_active Expired - Lifetime
- 2003-01-03 AT AT03700018T patent/ATE302201T1/de not_active IP Right Cessation
- 2003-01-03 CA CA002472331A patent/CA2472331A1/en not_active Abandoned
- 2003-01-03 JP JP2003558006A patent/JP2005514421A/ja not_active Withdrawn
- 2003-01-03 PT PT03700018T patent/PT1463725E/pt unknown
- 2003-01-03 BR BR0306730-0A patent/BR0306730A/pt not_active IP Right Cessation
- 2003-01-07 US US10/337,635 patent/US6759534B2/en not_active Expired - Fee Related
- 2003-01-07 AR ARP030100032A patent/AR038267A1/es active IP Right Grant
-
2004
- 2004-06-17 ZA ZA200404798A patent/ZA200404798B/en unknown
-
2005
- 2005-06-22 HK HK05105183A patent/HK1072598A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200302098A (en) | 2003-08-01 |
| DK1463725T3 (da) | 2005-11-21 |
| EP1463725B1 (de) | 2005-08-17 |
| DE60301324D1 (de) | 2005-09-22 |
| CN1615307A (zh) | 2005-05-11 |
| BR0306730A (pt) | 2004-12-21 |
| ZA200404798B (en) | 2006-02-22 |
| AU2003200847A1 (en) | 2003-07-24 |
| TWI250980B (en) | 2006-03-11 |
| US6759534B2 (en) | 2004-07-06 |
| CN1269814C (zh) | 2006-08-16 |
| ATE302201T1 (de) | 2005-09-15 |
| PT1463725E (pt) | 2005-10-31 |
| WO2003057691A1 (en) | 2003-07-17 |
| RU2278116C2 (ru) | 2006-06-20 |
| MXPA04005646A (es) | 2004-12-06 |
| RU2004121026A (ru) | 2006-01-10 |
| ES2246464T3 (es) | 2006-02-16 |
| AR038267A1 (es) | 2005-01-12 |
| HUP0500031A2 (hu) | 2005-04-28 |
| HK1072598A1 (en) | 2005-09-02 |
| CA2472331A1 (en) | 2003-07-17 |
| DE60301324T2 (de) | 2006-05-24 |
| JP2005514421A (ja) | 2005-05-19 |
| PL371258A1 (en) | 2005-06-13 |
| KR100604502B1 (ko) | 2006-07-25 |
| EP1463725A1 (de) | 2004-10-06 |
| KR20040072710A (ko) | 2004-08-18 |
| US20030162969A1 (en) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003206028A1 (en) | Antidiabetic agents | |
| GB0115517D0 (en) | Novel antidiabetic agents | |
| AU2003219942A8 (en) | Composition and process for well cleaning | |
| EP1550657A4 (de) | Aminverbindungen und deren verwendung | |
| AU2003253188A8 (en) | Novel processes and intermediates for preparing triazolo-pyridines | |
| GB0222909D0 (en) | Novel process and intermediates | |
| GB0221513D0 (en) | Novel compounds and processes | |
| HK1080487A1 (en) | Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof | |
| AP2147A (en) | A composition for treating aids and associated conditions. | |
| GB0222912D0 (en) | Novel process and intermediates | |
| GB0123961D0 (en) | Process and intermediates | |
| GB0220385D0 (en) | Compound and process | |
| HK1072598A1 (en) | Process and intermediates for pyridazinone antidiabetic agents | |
| AU2003215804A1 (en) | Antidiabetic agents | |
| SI1463725T1 (sl) | Postopek in intermediati za piridazinonska antidiabeticna sredstva | |
| AUPS337802A0 (en) | Method of screening for antidiabetic agents | |
| GB0202187D0 (en) | "Inhibitors" | |
| AU2003215803A1 (en) | Antidiabetic agents | |
| AU2003213281A8 (en) | Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles | |
| GB0113298D0 (en) | Purification process and intermediates | |
| IL166087A0 (en) | Process for preparing nateglinide and intermediates thereof | |
| GB0215867D0 (en) | Novel method and compounds | |
| GB0206657D0 (en) | Novel intermediate and process | |
| HUP0402141A3 (en) | Herbicidal composition and process for its use | |
| GB0211751D0 (en) | Compound and process |